Who mentions $IPGP most on Surfaced?

@investmentguru_ (InvestmentGuru) mentions $IPGP most — 9 mentions in the past 12 months.

When was $IPGP first mentioned on Surfaced?

The earliest tracked mention of $IPGP in the Surfaced archive was on Jan 12, 2026.

How many voices track $IPGP?

6 FinTwit voices have mentioned $IPGP 14 times in the past 12 months.

What kind of voices mention $IPGP most?

$IPGP is mentioned most by Long Research voices on Surfaced.

Last 12mo stats

mentions

voices

$IPGP

IPG Photonics Corp

$IPGP

IPG Photonics Corp

Past 12mo:14mentions6voices

All voices1 call since May 2026show all

Loading price chart…

About this stock

$IPGP received 14 mentions from 6 distinct FinTwit voices over the past 12 months, with the first mention appearing on January 12, 2026, and the most recent on May 16, 2026. @investmentguru_ (InvestmentGuru) dominated the conversation with 9 mentions, while @crux_capital_, @frenchie_, @jasonl_capital, and @michaelsikand each contributed 1 mention. The primary discussion category focused on long research, with voices analyzing the company's positioning within broader technology trends.

AI-generated from tracked posts · updated Sep 5, 2026

Frequently asked

Related stocks

$VECOVeeco Instruments

$POWLPowell Industries

$SYNASynaptics

$GNRCGenerac Holdings

Recent calls

1 call

@thevalueistMay 10, 2026 · 11:12 PM

$IPGP IPG Photonics: The Strategic Pivot, Path to Recovery, and Investment Thesis. IPG Photonics is the dominant player in fiber lasers, but dominance in industrial cutting has become a more complicated position to hold. Chinese competitors have driven sustained price pressure in that segment, and the margin profile that once defined IPG's quality premium has eroded as a result. The strategic response — pivoting toward medical technology, battery welding, and defense — is the right directional move, but it's an early-stage reorientation against a backdrop of near-term financial pressure. Recent results show demand recovering and revenue growing, which confirms that the core business remains viable. The more important question is whether that top-line recovery translates into margin restoration, and the answer so far is incomplete. Free cash flow conversion has been inconsistent, and profitability hasn't yet reflected the volume improvement in a way that validates the thesis. Leadership has been overhauled. The new CEO is focused on operational discipline and broadening the product portfolio toward integrated laser systems — a higher-value configuration that moves IPG up the stack from component supplier to solutions provider. That's the right ambition, but integrated systems require different sales motions, longer customer relationships, and more complex delivery capabilities than standalone laser units. The organizational transition to support that shift is still underway. The valuation is carrying a recovery premium that the financials haven't yet earned. The stock is pricing in a successful execution of the strategic pivot, which means margin expansion and free cash flow improvement need to materialize on a visible timeline to justify current levels. A high-quality business with a credible long-term direction, but the entry point demands that the complex pieces — new leadership, new markets, new product configurations — come together with reasonable speed. The upside is real if the pivot lands. Medical, battery, and defense are structurally better markets than commodity industrial cutting, and IPG's technical foundation is strong enough to compete credibly in all three. The risk is execution timeline — the gap between strategic intent and financial proof points is still wide, and the stock doesn't offer much patience buffer at current multiples.

Open on X